sm 1 peptide has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Du, RH; Liu, J; Qin, SY; Shi, LS; Tan, RX; Zhou, ZQ; Zhu, XY | 1 |
1 other study(ies) available for sm 1 peptide and Atherogenesis
| Article | Year |
|---|---|
Fumigaclavine C activates PPARĪ³ pathway and attenuates atherogenesis in ApoE-deficient mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Ergot Alkaloids; Indole Alkaloids; Male; Mice; Mice, Inbred C57BL; PPAR gamma | 2014 |